Use of cookies

Lund University uses cookies to ensure that the website functions properly and to improve your experience.

Read more in our cookie policy

Search results

Filter

Reset filter

Filetype

Your search for "30k fc points Coinsnight.com FC 26 coins 30% OFF code: FC2026. Rapid response to all my inquiries.eAnE" yielded 65568 hits

Kristian Gustafsson

Associate senior lecturer Contact details Email: kristian [dot] gustafsson [at] jur [dot] lu [dot] se Phone: +46 46 222 12 40Organisation Department of Law Room number: 306 Service point: 56 WebpageKristian Gustafssons profile in Lund University research portalOther affiliations Researcher Norma Research Programme Researcher Dispute resolution Publications Displaying of publications. Sorted by yea

https://www.law.lu.se/kristian-gustafsson - 2026-07-21

Anna Sonnsjö Andersson

Doctoral student Contact details Email: anna [dot] sonnsjo_andersson [at] jur [dot] lu [dot] se Phone: +46 46 222 12 69Organisation Department of Law Room number: 234 Service point: 56 WebpageAnna Sonnsjö Anderssons profile in Lund University research portalOther affiliations Researcher Law and Vulnerabilities Researcher Criminal Law Publications Displaying of publications. Sorted by year, then ti

https://www.law.lu.se/anna-sonnsjo-andersson - 2026-07-21

No title

This study prospectively evaluated the rate of biologic response to desmopressin (DDAVP) in 66 patients with type I or 2 von Willebrand disease (VWD), each of whom had, on the basis of available records, a clinically significant bleeding history and at least one of the following laboratory abnormalities: bleeding time (BT) longer than 15 minutes, ristocetin cofactor activity (VWF:RCo) less than 10

No title

Aims: Maintainance of glucagon response to hypoglycaemia is important as a safeguard against hypoglycaemia during glucose-lowering therapy in type 2 diabetes. During recent years, DPP-4 (dipeptidyl peptidase-4) inhibition has become more commonly used in elderly patients. However, whether DPP-4 inhibition affects the glucagon response to hypoglycaemia in the elderly is not known and was the aim of

No title

PURPOSE: In the ENGOT-OV16/NOVA trial (ClinicalTrials.gov identifier: NCT01847274), maintenance therapy with niraparib, a poly(ADP-ribose) polymerase inhibitor, prolonged progression-free survival in patients with platinum-sensitive, recurrent ovarian cancer who had a response to their last platinum-based chemotherapy. The objective of the study was to assess the clinical benefit and patient-repor

No title

In the CONVINCE trial, the primary analysis demonstrated a survival benefit for patients receiving high-dose hemodiafiltration (HDF) as compared with high-flux hemodialysis (HD). A secondary objective was to evaluate effects on health-related quality of life (HRQoL); assessed in eight domains (physical function, cognitive function, fatigue, sleep disturbance, anxiety, depression, pain interference